A Pilot Study of Aminolaevulinic Acid (ALA) Photodynamic Therapy (PDT) in Patients With Cervical Persistent High Risk HPV Infection or Cervical Intraepithelial Neoplasia
Phase of Trial: Phase II
Latest Information Update: 04 May 2017
At a glance
- Drugs Aminolevulinic acid (Primary)
- Indications Cervical cancer
- Focus Therapeutic Use
- Sponsors Shanghai Fudan-Zhangjiang Bio-Pharmaceutical
- 14 Apr 2017 Status changed from active, no longer recruiting to completed.
- 09 Dec 2015 Planned primary completion date changed from 1 Oct 2015 to 1 Nov 2016, as reported by ClinicalTrials.gov.
- 09 Dec 2015 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.